Get started
Author

Vasiliki Rapti

Observed names: V Rapti, V. Rapti, VASILIKI RAPTI, Vasiliki E Rapti, Vasiliki E. Rapti
Observed institutions: Hôpital Necker-Enfants Malades, Howard Hughes Medical Institute, Inserm, Duke University, National and Kapodistrian University of Athens, Université Paris Cité, Tan Tock Seng Hospital, Assistance Publique – Hôpitaux de Paris, Hellenic Cooperative Oncology Group, St Savas Hospital, Hygeia Hospital, Duke Medical Center, University General Hospital Attikon, Duke University Health System, National Centre for Infectious Diseases, National Center for Epidemiology, Institut des Maladies Génétiques Imagine, Sotiria General Hospital, University of Virginia, Rockefeller University, Hellenic Center for Disease Control & Prevention
ORCID: 0000-0002-8322-635X
Observed ORCID: 0000-0002-8322-635X
OpenAlex ID: A5040990422
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
2020 · Ioanna-Evdokia Galani, Nikoletta Rovina, et al. · Nature Immunology · 501
PDF
The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
2019 · Ilias Karaiskos, Styliani Lagou, et al. · Frontiers in Public Health · 288
PDF
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
2022 · Jérémy Manry, Paul Bastard, et al. · Proceedings of the National Academy of Sciences · 194
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
2022 · Qian Zhang, Andrés Pizzorno, et al. · The Journal of Experimental Medicine · 132
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study
2022 · Evangelos Oikonomou, Nektarios Souvaliotis, et al. · Vascular Pharmacology · 124
The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence
2019 · Paraskevi Fragkou, Garyfallia Poulakou, et al. · Microorganisms · 69
PDF
Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries
2021 · Guy Berbers, Pieter van Gageldonk, et al. · Nature Communications · 68
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19
2020 · Mina Psichogiou, Andreas Karabinis, et al. · PLoS ONE · 54
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study
2021 · GARYPHALLIA POULAKOU, EVANGELOS DIMAKAKOS, et al. · In Vivo · 24
PDF
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
2024 · Ioannis Grigoropoulos, Georgios Tsioulos, et al. · Respiratory Research · 21
PDF
The Gordian Knot of C. auris: If You Cannot Cut It, Prevent It
2023 · Vasiliki Rapti, Katerina Iliopoulou, et al. · Pathogens · 16
PDF
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece
2023 · Helena C. Maltezou, Dimitrios Basoulis, et al. · Vaccine · 16
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
2022 · Vasiliki Rapti, Thomas Tsaganos, et al. · Vaccines · 14
PDF
The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground
2025 · Vasiliki Rapti, Efthymia Giannitsioti, et al. · Journal of Clinical Medicine · 12
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
2025 · Amalia Papanikolopoulou, Vasiliki Rapti, et al. · Pathogens · 11
PDF
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
2022 · Christina Papanikolaou, Vasiliki Rapti, et al. · Vaccines · 10
PDF
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation
2022 · Ioannis P. Trontzas, Vasiliki E. Rapti, et al. · Journal of Chemotherapy · 10
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study
2015 · Georgia Kourlaba, Vasiliki Rapti, et al. · BMC Health Services Research · 10
PDF
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice
2023 · Nikos Pantazis, Evmorfia Pechlivanidou, et al. · Microorganisms · 8
PDF
Enteric Plexus Neuropathy Associated with PD-L1 Blockade in a Patient with Small-Cell Lung Cancer
2021 · Ioannis P Trontzas, Vasiliki E Rapti, et al. · Immunotherapy · 7
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
2022 · Vasilis Petrakis, Vasiliki Rapti, et al. · Microorganisms · 6
PDF
Prone Positioning in Patients With COVID-19: Analysis of Multicenter Registry Data and Meta-analysis of Aggregate Data
2021 · ANASTASIOS KOLLIAS, KONSTANTINOS G. KYRIAKOULIS, et al. · In Vivo · 6
PDF
Knowledge and Perceptions about COVID-19 among Health Care Workers: Evidence from COVID-19 Hospitals during the Second Pandemic Wave
2021 · Petros Ioannou, Stamatis Karakonstantis, et al. · Tropical Medicine and Infectious Disease · 6
PDF
Works count: 55
Citation count: 1,723
H-index: 15
I10-index: 21
Year
Topic
Type